Business
Business
Climate advocacy group calls out property insurers for fossil fuel support
July 10, 2024
Climate advocacy group calls out property insurers for fossil fuel support
Breadcrumb Trail Links PMN Energy PMN Business Author of the article: The Canadian Press Ian Bickis Published Jul 10, 2024…
Mastering Market Volatility for Maximum Gains – Modest Money
July 10, 2024
Mastering Market Volatility for Maximum Gains – Modest Money
Looking to harness the power of significant market movements? The long strangle option strategy might be your gateway to capitalizing…
Hoffmann Green Signs a Key Licensing Agreement in the United States
July 10, 2024
Hoffmann Green Signs a Key Licensing Agreement in the United States
Article content Entrance fees of €20 million, including 2 million guaranteed Business model including entrance fees, royalties and the sale…
A Strategic Approach For Stable Markets – Modest Money
July 10, 2024
A Strategic Approach For Stable Markets – Modest Money
Looking for a way to profit from a market that doesn’t move much? The iron condor option strategy might be…
Oil Steady as US Inventory Drop Vies With China Demand Concerns
July 10, 2024
Oil Steady as US Inventory Drop Vies With China Demand Concerns
Article content (Bloomberg) — Oil steadied as signs of another inventory draw in the US were balanced out by concerns…
Universal Music UK restructures, merging Island and EMI labels while launching new Audience and Media Division
July 10, 2024
Universal Music UK restructures, merging Island and EMI labels while launching new Audience and Media Division
Universal Music UK is changing its company structure from October 1. This will include the merger of two renowned London-based…
Mastering The Bear Call Credit Spread Strategy To Profit During Downturns – Modest Money
July 10, 2024
Mastering The Bear Call Credit Spread Strategy To Profit During Downturns – Modest Money
Are you ready to discover a strategy that can help you profit from stagnant or falling stock prices, all while…
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal aging-related neurodegeneration, Parkinson’s disease, and Alzheimer’s disease
July 10, 2024
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal aging-related neurodegeneration, Parkinson’s disease, and Alzheimer’s disease
This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing…
Songwriter groups hail ‘landmark victory’ as US Copyright Office issues rule confirming how termination rights apply to streaming royalties
July 9, 2024
Songwriter groups hail ‘landmark victory’ as US Copyright Office issues rule confirming how termination rights apply to streaming royalties
A number of organizations representing artists and songwriters in the United States have applauded the US Copyright Office’s ruling reaffirming…
Master The Diagonal Spread Strategy In Order To Unlock Profit Potential – Modest Money
July 9, 2024
Master The Diagonal Spread Strategy In Order To Unlock Profit Potential – Modest Money
Are you looking to enhance your options trading with strategies that balance risk and reward over time? The diagonal spread…